Research indicates that skeletal muscle atrophy is primarily associated with abnormal activation of the ubiquitin-proteasome system, with CARM1 playing a crucial regulatory role in this process (Tintignac et al., 2015). The gene discussed is CARM1; the disease is muscle atrophy.